LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Takeda Pharmaceutical Co Ltd ADR

Suletud

14.8 -0.74

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

14.8

Max

14.82

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

-9.52 downside

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Takeda Pharmaceutical Co Ltd ADR Graafik

Seotud uudised

31. juuli 2024, 07:19 UTC

Tulu

Takeda Pharmaceutical's First-Quarter Profit Rose on Higher Revenue -- Update

31. juuli 2024, 06:29 UTC

Tulu

Takeda Pharmaceutical Reports Rise in First-Quarter Net Profit on Higher Revenue

17. juuni 2024, 13:34 UTC

Suurimad hinnamuutused turgudel

Ovid Therapeutics Shares Slide Premarket After Takeda's Soticlestat Setback

13. mai 2024, 11:26 UTC

Suurimad hinnamuutused turgudel

AC Immunity Shares Soar on Exclusive License Deal with Takeda

9. mai 2024, 07:37 UTC

Tulu

Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss -- Update

9. mai 2024, 07:08 UTC

Tulu

Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss

1. veebr 2024, 07:32 UTC

Tulu

Takeda Pharmaceutical's Third-Quarter Net Profit Dropped on Lower Margins -- Update

1. veebr 2024, 06:55 UTC

Tulu

Takeda Pharmaceutical's Third-Quarter Net Profit Dropped on Lower Margins

31. jaan 2024, 23:58 UTC

Suurimad hinnamuutused turgudel

Protagonist Therapeutics Shares Rise 5.6% on Licensing Deal With Takeda

27. okt 2023, 01:24 UTC

Suurimad hinnamuutused turgudel

Takeda Pharmaceutical Shares Slump After It Books 2Q Loss, Cuts Profit Guidance

26. okt 2023, 08:57 UTC

Tulu

Takeda Pharmaceutical Books Second-Quarter Loss, Lowers Profit Guidance -- Update

26. okt 2023, 07:14 UTC

Tulu

Takeda Pharmaceutical Books Second-Quarter Net Loss on Impairment of Certain Products

Võrdlus sarnastega

Hinnamuutus

Takeda Pharmaceutical Co Ltd ADR Prognoos

Hinnasiht

By TipRanks

-9.52% langus

12 kuu keskmine prognoos

Keskmine 13.4 USD  -9.52%

Kõrge 13.4 USD

Madal 13.4 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Takeda Pharmaceutical Co Ltd ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

1 ratings

0

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

14.79 / 14.94Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence